東北證券(000686.SZ):2022年度淨利預降85.81%
格隆匯1月18日丨東北證券(000686.SZ)公佈2022年度業績預吿,公司預計實現歸屬於上市公司股東的淨利潤為2.3億元,同比下降85.81%;預計實現扣除非經常性損益後的淨利潤為2.23億元,同比下降85.93%。
2022年,國際形勢複雜嚴峻,國內疫情衝擊不斷,我國經濟面臨較大下行壓力,證券市場各主要指數出現不同幅度下跌。公司堅持聚焦“十四五”戰略規劃和年度經營目標,加大長期戰略性投入,全面推進財富管理和數字化轉型,各項業務平穩發展;但受市場波動影響,公司投資業務、投行業務盈利表現不及預期,公司整體業績出現較大幅度下滑。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.